Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yuichi Muraki"'
Autor:
Yu Nobuoka, Shugo Mizuno, Kouhei Nishikawa, Kaname Nakatani, Yuichi Muraki, Tomomi Yamada, Masahiro Okuda, Tsutomu Nobori, Yoshiki Sugimura, Shuji Isaji
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Seventy living donor liver transplantation (LDLT) and 39 kidney transplantation (KT) patients were randomly screened by using the peripheral blood CD4+ adenosine triphosphate activity (ATP) assay (IMK assay). The patients were divided into 2 groups i
Externí odkaz:
https://doaj.org/article/c398cffec5174bfb9bd49491888a3e90
Autor:
Shugo Mizuno, Yuichi Muraki, Kaname Nakatani, Akihiro Tanemura, Naohisa Kuriyama, Ichiro Ohsawa, Yoshinori Azumi, Masashi Kishiwada, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Norihiko Yamamoto, Tomomi Yamada, Katsuya Shiraki, Yoshiyuki Takei, Tsutomu Nobori, Masahiro Okuda, Shuji Isaji
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Aim. To evaluate whether the combination of the peripheral blood CD4+ adenosine triphosphate activity (ATP) assay (ImmuKnow assay: IMK assay) and cytochrome P450 3A5 (CYP3A5) genotype assay is useful for monitoring of immunological aspects in the pat
Externí odkaz:
https://doaj.org/article/b611ed07ef3d4001b404b4f6d8978841
Publikováno v:
Hematological Oncology.
Publikováno v:
Clinical Pharmacology in Drug Development. 9:175-188
Teicoplanin is an antibiotic agent used for the treatment of Gram-positive infections. The clinical benefit of teicoplanin is associated with its blood concentrations, but the optimal dosing regimen is not yet known. To explore the optimal individual
Autor:
Shugo Mizuno, Yuko Sakamoto, Yuichi Muraki, Takashi Hamada, Kaname Nakatani, Shuji Isaji, Masanobu Usui, Hiroyuki Sakurai, Masashi Kishiwada, Tsutomu Nobori, Junji Nishioka, Masami Tabata, Masahiro Okuda
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 18:226-234
The immune response after living donor liver transplantation (LDLT) was evaluated, with specific attention focused on the inter-relationship among clinical conditions, pharmacokinetics of tacrolimus, and cytochrome P450 3A5 (CYP3A5) genotypes.Forty 4